Results 131 to 140 of about 21,848 (263)

Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmodium falciparum malaria in Peru

Brazilian Journal of Infectious Diseases
The efficacy and safety of a fixed-dose combination of atovaquone and proguanil hydrochloride (MalaroneTM) were compared with chloroquine or pyrimethamine/sulfadoxine in patients with acute falciparum malaria in northern Peru.
A. Llanos-Cuentas, P. Campos, M. Clendenes, C. J. Canfield, D. B. A. Hutchinson   +4 more
doaj   +1 more source

A Molecular Surveillance System for Global Patterns of Drug Resistance in Imported Malaria

Emerging Infectious Diseases, 2003
Analysis of imported malaria in travelers may represent a novel surveillance system for drug-resistant malaria. We analyzed consecutive falciparum malaria isolates from Canadian travelers from 1994 to 2000, for polymorphisms in pfcrt, dhfr, and dhps ...
Annie-Claude Labbé, Samir N. Patel, Ian Crandall, Kevin C. Kain   +3 more
doaj   +1 more source

Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine-Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India.

American Journal of Tropical Medicine and Hygiene, 2018
In most of India, sulfadoxine-pyrimethamine (SP) plus artesunate serves as first-line treatment for uncomplicated falciparum malaria. In 112 clinical Plasmodium falciparum isolates from Mangaluru, southwestern India, we sequenced molecular markers ...
J. Wedam, Costanza Tacoli, Prabhanjan P. Gai, Konrad Siegert, S. Kulkarni, Rashmi Rasalkar, A. Boloor, A. Jain, C. Mahabala, Shantaram B. Baliga, Damodara Shenoy, Rajeshwari Devi, P. Gai, F. Mockenhaupt   +13 more
semanticscholar   +1 more source

Review of pyronaridine anti-malarial properties and product characteristics. [PDF]

, 2012
Pyronaridine was synthesized in 1970 at the Institute of Chinese Parasitic Disease and has been used in China for over 30 years for the treatment of malaria.
Arbe-Barnes, Sarah J, Borghini-Fuhrer, Isabelle, Craft, J Carl, Croft, Simon L, Duparc, Stephan, Fleckenstein, Lawrence, Rim, Han-Jong, Shin, Chang-Sik   +7 more
core   +2 more sources

Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia

Drug Design, Development and Therapy, 2023
Loeki Enggar Fitri,1,2 Aulia Rahmi Pawestri,1,2 Nuning Winaris,1,2 Agustina Tri Endharti,1 Alif Raudhah Husnul Khotimah,3,4 Hafshah Yasmina Abidah,3,4 John Thomas Rayhan Huwae3,5 1Department of Parasitology Faculty of Medicine, Universitas Brawijaya ...
Fitri LE, Pawestri AR, Winaris N, Endharti AT, Khotimah ARH, Abidah HY, Huwae JTR   +6 more
doaj  

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial

PLoS Medicine, 2016
Background In Africa, most plasmodium infections during pregnancy remain asymptomatic, yet are associated with maternal anemia and low birthweight.
M. Madanitsa, Linda Kalilani, V. Mwapasa, A. V. van Eijk, Carole Khairallah, Doreen Ali, Cheryl Pace, James Smedley, K. Thwai, Brandt Levitt, Duolao Wang, A. Kang’ombe, B. Faragher, S. Taylor, S. Meshnick, F. T. ter Kuile   +15 more
semanticscholar   +1 more source

Factors Associated with Prenatal Folic Acid and Iron Supplementation Among 21,889 Pregnant women in Northern Tanzania: A Cross-Sectional Hospital-Based Study. [PDF]

, 2012
Folate and iron deficiency during pregnancy are risk factors for anaemia, preterm delivery, and low birth weight, and may contribute to poor neonatal health and increased maternal mortality.
Daltveit, Anne Kjersti, Hoyo, Cathrine, Lie, Rolv Terje, Manongi, Rachael, Ogundipe, Olukemi, Oneko, Olola, Østbye, Truls   +6 more
core   +4 more sources

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon

Bulletin of the World Health Organization, 2002
OBJECTIVE: To evaluate the therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine, and the sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
Basco Leonardo K., Same-Ekobo Albert, Ngane Vincent Foumane, Ndounga Mathieu, Metoh Theresia, Ringwald Pascal, Soula Georges   +6 more
doaj  

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up

South African Family Practice, 2002
Objective: To assess the failure rate of the present first line treatment regime for uncomplicated falciparum malaria of sulfadoxine/pyrimethamine combined with chloroquine. Design: A before-after study. Setting: Ndumo Clinic, Ingwavuma District, South
C.H. Vaughan Williams, C. La Cock, G.F.J. Henry, A.J. Ross   +3 more
doaj   +1 more source

Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi

Malaria Journal, 2016
BackgroundMalawi experienced prolonged use of sulfadoxine/pyrimethamine (SP) as the front-line anti-malarial drug, with early replacement of chloroquine and delayed introduction of artemisinin-based combination therapy.
M. Ravenhall, E. D. Benavente, M. Mipando, Anja T. R. Jensen, C. Sutherland, C. Roper, N. Sepúlveda, D. Kwiatkowski, Jacqui Montgomery, K. Phiri, Anja D Terlouw, A. Craig, S. Campino, Harold Ocholla, T. Clark   +14 more
semanticscholar   +1 more source